Psychiatrie pro praxi – 3/2019

www.psychiatriepropraxi.cz  / Psychiatr. praxi 2020; 21(e3): e3–e14 / PSYCHIATRIE PRO PRAXI e12 PŘEHLEDOVÉ ČLÁNKY Klinický význam genetického testování u pacientů s poruchou autistického spektra 29a. van Rijn S. Social Attention in 47,XXY (Klinefelter Syndrome): Visual Scanning of Faci- al Expressions Using Eyetracking. J Int Neuropsychol Soc 2015; 21: 364–372. doi: 10.1017/ S1355617715000302. 29b. van Rijn S, Stockmann L, van Buggenhout G, et al. Social cognition and under- lying cognitive mechanisms in children with an extra X chromosome: a comparis- on with autism spectrum disorder. Genes Brain Behav 2014; 13: 459–467. doi: 10.1111/ gbb.12134. 30. Richards C, Jones C, Groves L, et al. Prevalence of autism spectrum disorder phenome- nology in genetic disorders: a systematic review and meta-analysis. The Lancet Psychiatry 2015; 2: 909–916. doi: 10.1016/S2215-0366(15)00376-4. 31. Moss J, Richards C, Nelson L, et al. Prevalence of autism spectrum disorder symptoma- tology and related behavioural characteristics in individuals with Down syndrome. Auti- sm 2012; 17: 390–404. doi: 10.1177/1362361312442790. 32. Chien W-H, Gau SS-F, Wu Y-Y, et al. Identification and molecular characterization of two novel chromosomal deletions associated with autism. Clin Genet 2010; 78: 449-456. doi: 10.1111/j.1399-0004.2010.01395.x. 33. Bergbaum A, Ogilvie CM. Autism and chromosome abnormalities-A review. Clin Anat 2016; 29: 620–627. doi: 10.1002/ca.22719. 34. Liu S, Song L, Cram DS, et al. Traditional karyotyping vs copy number variation sequen- cing for detection of chromosomal abnormalities associated with spontaneous miscarri- age. Ultrasound Obstet Gynecol 2015; 46: 472–477. doi: 10.1002/uog.14849. 35. Schuch JB, Paixão-Côrtes VR, Longo D, et al. Analysis of a Protein Network Related to Copy Number Variations in Autism Spectrum Disorder. J Mol Neurosci 2019; 69: 140–149. doi: 10.1007/s12031-019-01343-7. 36. Coe BP, Stessman HAF, Sulovari A, et al. Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity. Nat Genet 2019; 51: 106–116. doi: 10.1038/s41588-018-0288-4. 37. Barone R, Gulisano M, Amore R, et al. Clinical correlates in children with autism spec- trum disorder and CNVs: systematic investigation in a clinical setting. Int J Dev Neurosci 2020; [Epub ahead of print]. doi: 10.1002/jdn.10024. 38. Capkova Z, Capkova P, Srovnal J, et al. Differences in the importance of microcephaly, dysmorphism, and epilepsy in the detection of pathogenic CNVs in ID and ASD patients. PeerJ 2019; 7: e7979. doi: 10.7717/peerj.7979. 39. Werling AM, Grünblatt E, Oneda B, et al. High-resolution chromosomal microarray ana- lysis for copy-number variations in high-functioning autism reveals large aberration typi- cal for intellectual disability. J Neural Transm (Vienna) 2020; 127: 81–94. doi: 10.1007/s00702- 019-02114-9. 40. Crespi BJ, Procyshyn TL. Williams syndrome deletions and duplications: Genetic win- dows to understanding anxiety, sociality, autism, and schizophrenia. Neurosci Biobehav Rev 2017; 79: 14–26. doi: 10.1016/j.neubiorev.2017.05.004. 41. Dykens EM, Roof E, Hunt-Hawkins H, et al. Diagnoses and characteristics of autism spec- trum disorders in children with Prader-Willi syndrome. J Neurodev Disord 2017; 9: 18. doi: 10.1186/s11689-017-9200-2. 42. Wang T-S, Tsai W-H, Tsai L-P, et al. Clinical characteristics and epilepsy in genomic im- printing disorders: Angelman syndrome and Prader–Willi syndrome. Ci Ji Yi Xue Za Zhi 2019; 32: 137–144. doi: 10.4103/tcmj.tcmj_103_19. 43. Angkustsiri K, Goodlin-Jones B, Deprey L, et al. Social Impairments in Chromo- some 22q11.2 Deletion Syndrome (22q11.2DS): Autism Spectrum Disorder or a Dif- ferent Endophenotype? J Autism Dev Disord 2014; 44: 739–746. doi: 10.1007/s10803- 013-1920-x. 44. Miller DT, Adam MP, Aradhya S, et al. Consensus Statement: Chromosomal Microa- rray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disa- bilities or Congenital Anomalies. Am J Hum Genet 2010; 86: 749–764. doi: 10.1016/j. ajhg.2010.04.006. 45. Voelkerding KV, Dames SA, Durtschi JD. Next-Generation Sequencing: From Basic Re- search to Diagnostics. Clin Chem 2009; 55: 641–658. doi: 10.1373/clinchem.2008.112789. 46. Schaaf CP, Betancur C, Yuen RKC, et al. A framework for an evidence-based gene list re- levant to autism spectrum disorder. Nat Rev Genet 2020; [Epub ahead of print]. doi: 10.1038/ s41576-020-0231-2. 47. Lovato DV, Herai RR, Pignatari GC, et al. The Relevance of Variants With Unknown Sig- nificance for Autism Spectrum Disorder Considering the Genotype–Phenotype Interrela- tionship. Front Psychiatry 2019; 10: 409. doi: 10.3389/fpsyt.2019.00409/full. 48. Cukier HN, Dueker ND, Slifer SH, et al. Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders. Mol Autism 2014; 5: 1. doi: 10.1186/2040-2392-5-1. 49. Aspromonte MC, Bellini M, Gasparini A, et al. Characterization of intellectual disabili- ty and autism comorbidity through gene panel sequencing. Hum Mutat 2019; 40: 1346– 1363. doi: 10.1002/humu.23822. 50. Han JY, Jang JH, Park J, et al. Targeted Next-Generation Sequencing of Korean Patients With Developmental Delay and/or Intellectual Disability. Front Pediatr 2018; 6: 391. doi: 10.3389/fped.2018.00391/full. 51. Du X, Gao X, Liu X, et al. Genetic Diagnostic Evaluation of Trio-Based Whole Exome Sequencing Among Children With Diagnosed or Suspected Autism Spectrum Disorder. Front Genet 2018; 9: 594. doi: 10.3389/fgene.2018.00594.